• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Cybersecurity Challenges Leave Medical Device Makers Insecure

    OEMs Are Demanding Designs that Challenge Suppliers

    Diabetes Technology Manufacturers Seemingly on a Sugar Rush

    Post-Pandemic Partnerships: A Full-Service Outsourcing Discussion

    Discovering the Value of Surface Treatments and Coatings for Medtech
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    Anumana's ECG Pulmonary Hypertension AI Algorithm Gains Breakthrough Status

    inHEART's 3D Cardiac Modeling Tool Earns FDA Nod

    FDA OKs RapidAI's Pulmonary Embolism Triage, Notification Tool

    Kilo Health Invests 500,000 Euros in Pulsetto

    China to Strengthen Robotic Surgical Market With Second 5-Year Plan
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Cybersecurity Challenges Leave Medical Device Makers Insecure

    OEMs Are Demanding Designs that Challenge Suppliers

    Diabetes Technology Manufacturers Seemingly on a Sugar Rush

    Post-Pandemic Partnerships: A Full-Service Outsourcing Discussion

    Discovering the Value of Surface Treatments and Coatings for Medtech
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Injecting Neurostimulators into Blood Vessels (We Swear, It’s Not Sci-Fi)

    Understanding the Costs of Care in the OR

    Sick of Being Sick: Pandemic Fatigue Flares at AAOS

    Managing Critical Healthcare Supply Chains in Turbulent Times

    To Drive Value, Human Capital Leaders Turn to Outsourced Solutions
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Xact Wire EDM Corp.

    Cirtec Medical

    Fusion Biotec Inc.

    Concise Engineering

    Arthur G. Russell Co. Inc., The
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    3D Printing in Dental Prosthodontics, Orthodontics, and Surgery

    What New Tech Can Improve Your Medical Manufacturing Plant?

    Why Medical Device Firms Must Navigate the Muddy Waters of ESG Requirements

    Medical Device Servicing vs. Remanufacturing

    Digital Marketplaces for Medical Equipment Come of Age
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Xact Wire EDM Corp.

    Cirtec Medical

    Fusion Biotec Inc.

    Concise Engineering

    Arthur G. Russell Co. Inc., The
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Breaking News

    FDA Approves BIOTRONIK's Quadripolar Left Ventricular Lead & Multi-Pole Pacing

    Additions to ProMRI series ensure heart failure patients have access to MRI scans.

    FDA Approves BIOTRONIK
    Sentus ProMRI QP lead with MR conditional CRT-D
    FDA Approves BIOTRONIK
    MPP technology allows for greater customization of therapy to meet specific heart failure patient needs.
    Related CONTENT
    • FDA Approves Abbott's Portico with FlexNav TAVR System
    • CVRx Completes First Procedure With Ultrasound-Guided Implant Approach
    • FDA Approves ZOLL's remedē for Central Sleep Apnea
    • BioFourmis' Digital Heart Failure Therapeutic Earns Breakthrough Status
    • CARMAT Celebrates First Aeson Artificial Heart Commercial Implant
    PR Newswire05.09.17
    BIOTRONIK  announced FDA approval and the launch of Sentus ProMRI, the thinnest quadripolar left ventricular lead available in the United States. This introduction completes BIOTRONIK's second-generation ProMRI lead portfolio, which also includes Solia ProMRI and Plexa ProMRI.
     
    Sentus ProMRI is approved for use with heart failure devices based on data collected during the QP ExCELs study. The study, which included 53 sites in the United States, demonstrated Sentus ProMRI QP's best in class performance. Key data points include:
     
    • 97.1 percent complication-free rate at six months
    • 1.43 percent lead dislodgement rate
    • 93.4 percent of subjects achieved permanent pacing vector pacing threshold lower than 2.5 V at three months
     
    As more patients are living longer with cardiac conditions, BIOTRONIK continues to invest in research and development to bring solutions to market that improve quality of life for patients. Sentus ProMRI is a quadripolar coronary sinus left ventricular (LV) lead with an isodiametric design that marries co-radial wire insulation technology and polyurethane coating for maximum flexibility and reduced friction. The lead's four electrodes feature BIOTRONIK's proven fractal iridium coating to maximize performance.
     
    "With the array of leads available today, every patient should be implanted with an MR conditional device," said Dr. Venkat R. Iyer, electrophysiologist at Bayview Physicians Group in Norfolk, Virginia. "Our patients deserve nothing less than the best possible care. With MR conditional solutions, we can help ensure this continues throughout the patient care journey."
     
    Sentus ProMRI completes the ProMRI quadripolar system when used with BIOTRONIK's Inventra HF-T QP cardiac resynchronization therapy defibrillator (CRT-D), making it the only MR conditional heart failure solution available in the United States that delivers ultra-high energy (42J) therapy on the first and every shock. This system offers Closed Loop Stimulation (CLS)—BIOTRONIK's unique physiologic rate-adaptive algorithm that automatically optimizes to each patient's needs based on real-time metabolic demand. It also features BIOTRONIK Home Monitoring, which has shown a 50% reduction in mortality1 in patients with heart failure, as proven in the IN-TIME study.
     
    "After more than 50 years with zero lead recalls, we continue to invest in solutions that positively impact patient lives," said Marlou Janssen, president at BIOTRONIK Inc. "By equipping physicians with the most impactful cardiovascular solutions to confidently treat patients, we reinforce BIOTRONIK's dedication to advancing innovation that matters to health systems, physicians and patients."
     
    The company's MultiPole Pacing (MPP) technology was also approved, providing physicians with additional treatment options for heart failure patients who have been non-responsive to cardiac resynchronization therapy (CRT).2 MPP will be available on new BIOTRONIK CRT defibrillator (CRT-D) systems for patients with heart failure.
     
    Nearly 40 percent of heart failure patients are initially non-responsive to CRT.3 BIOTRONIK's innovative MPP technology addresses this challenge by enabling the left ventricle to be paced twice per cardiac cycle. Uniquely, these paces can be either sequential or simultaneous, allowing for greater customization of therapy to meet specific patient needs. BIOTRONIK CRT-D systems include MPP and feature ProMRI technology, providing patients with access to critical diagnostic imaging scans as needed. These devices are also equipped with MRI AutoDetect, a dedicated sensor that detects the MRI environment, converts the patient's device to MRI mode, and then automatically returns to its permanent program when the scan is complete.
     
    With the availability of MPP, BIOTRONIK now offers the most comprehensive MR conditional CRT portfolio available today to ensure physicians have access to the best possible cardiac rhythm management solution.
     
    "MultiPole Pacing is an important technology that allows physicians to tailor cardiac resynchronization therapy to each patient," said Dr. Gery Tomassoni, Baptist Health, Lexington, Kentucky. "Heart failure is a complex condition and physicians are routinely challenged to find the ideal treatment for unique disease presentations. Adding MPP technology to other key BIOTRONIK features creates more options for physicians to meet evolving patient needs."
     
    "When we develop technologies and evolve our devices, we think first and foremost about patients. Patients deserve the best care possible and innovation that truly enhances everyday life," said Janssen. "Patients with heart failure are the most complex to treat, and they often have additional comorbidities that are likely to change and worsen over time. BIOTRONIK rises to this challenge by continuing to innovate, and offering impactful, customizable solutions to physicians that meet the ever-changing landscape of patients' needs."
     
    BIOTRONIK's 360o CRT technologies are designed to better equip physicians to meet the therapy needs of heart failure patients. These technologies include:
     
    • MultiPole Pacing—enables left ventricle to be paced sequentially or simultaneously
    • MRI AutoDetect— shortens window of reduced therapy and eliminates the need for post-MRI reprogramming
    • Closed Loop Stimulation—equips the device to respond appropriately to physiologic demands and acute mental stress
    • Ultra-High Energy CRT defibrillator—provides up to 42J of energy to meet patient needs on first and every shock
    • CRT-DX system—allows full CRT-D therapy with only two leads
    • BIOTRONIK Home Monitoring—automatically transmits device data daily; proven to reduce mortality in patients with heart failure by 50%4
     
    References
    1Hindricks G, et al. The Lancet. 2014, 384 (9943).
    2Outcomes from use of BIOTRONIK MultiPole Pacing feature may be different than results obtained during St. Jude Medical MultiPoint Pacing (MPP) IDE study of their similar feature. The clinical effectiveness of this feature has not been established. BIOTRONIK is conducting an FDA-required post approval study to demonstrate that the MultiPole Pacing feature is effective by converting a percentage of CRT non-responders to responders. 
    3Mullens W et al. JACC. 2009, 53 (9).
    4Hindricks G, et al. The Lancet. 2014, 384 (9943).
    Related Searches
    • design
    • sensor
    • president
    • technologies
    Related Knowledge Center
    • Electronics
    • Cardiovascular
    Suggested For You
    FDA Approves Abbott FDA Approves Abbott's Portico with FlexNav TAVR System
    CVRx Completes First Procedure With Ultrasound-Guided Implant Approach CVRx Completes First Procedure With Ultrasound-Guided Implant Approach
    FDA Approves ZOLL FDA Approves ZOLL's remedē for Central Sleep Apnea
    BioFourmis BioFourmis' Digital Heart Failure Therapeutic Earns Breakthrough Status
    CARMAT Celebrates First Aeson Artificial Heart Commercial Implant CARMAT Celebrates First Aeson Artificial Heart Commercial Implant
    Study Confirms Benefits of ZOLL Study Confirms Benefits of ZOLL's Implantable Sleep Apnea Device
    VistaMed, OneProjects and Tyndall Receive €5.1 million to Improve Treatment of Cardiac Arrhythmias VistaMed, OneProjects and Tyndall Receive €5.1 million to Improve Treatment of Cardiac Arrhythmias
    Survey: Patient Focus Breeds Success for Remote Cardiac Monitoring Programs Survey: Patient Focus Breeds Success for Remote Cardiac Monitoring Programs
    FDA Approves Abiomed FDA Approves Abiomed's Next-Gen Impella RP for Right Heart Failure
    Expanded FDA Approval for Medtronic Expanded FDA Approval for Medtronic's Arctic Front Cryoablation Catheter
    Feinstein Institutes Scientists Develop Long-Term Vagus Nerve Implant Feinstein Institutes Scientists Develop Long-Term Vagus Nerve Implant
    GE Healthcare, ACC Team Up to Advance AI in Cardiac Care GE Healthcare, ACC Team Up to Advance AI in Cardiac Care
    Abiomed Buys preCARDIA, a Heart Failure Tech Firm Abiomed Buys preCARDIA, a Heart Failure Tech Firm
    Medtronic Two-Year Evolut Low-Risk TAVR Trial Results Released Medtronic Two-Year Evolut Low-Risk TAVR Trial Results Released
    Abbott Abbott's Navitor TAVI System Gains CE Mark

    Related Content

    • Cardiovascular
      FDA Approves Abbott

      FDA Approves Abbott's Portico with FlexNav TAVR System

      Self-expanding TAVR valve features intra-annular (within the native valve) leaflets.
      PR Newswire 09.20.21

    • Cardiovascular
      CVRx Completes First Procedure With Ultrasound-Guided Implant Approach

      CVRx Completes First Procedure With Ultrasound-Guided Implant Approach

      The new approach is the latest advancement in Barostim for treating heart failure symptoms.
      Globe Newswire 08.26.21

    • Neurological
      FDA Approves ZOLL

      FDA Approves ZOLL's remedē for Central Sleep Apnea

      Transvenous phrenic nerve stimulation for moderate to severe CSA approved.
      Business Wire 08.06.21


    • Cardiovascular | Digital Health
      BioFourmis

      BioFourmis' Digital Heart Failure Therapeutic Earns Breakthrough Status

      Augments guideline-directed use of heart failure medications.
      PR Newswire 07.30.21

    • Cardiovascular
      CARMAT Celebrates First Aeson Artificial Heart Commercial Implant

      CARMAT Celebrates First Aeson Artificial Heart Commercial Implant

      Represents first CARMAT sale, paves the way for the company’s commercial development.
      Business Wire 07.20.21


      Breaking News
      • Anumana's ECG Pulmonary Hypertension AI Algorithm Gains Breakthrough Status
      • inHEART's 3D Cardiac Modeling Tool Earns FDA Nod
      • FDA OKs RapidAI's Pulmonary Embolism Triage, Notification Tool
      • Kilo Health Invests 500,000 Euros in Pulsetto
      • China to Strengthen Robotic Surgical Market With Second 5-Year Plan
      View Breaking News >
      CURRENT ISSUE

      May 2022

      • Cybersecurity Challenges Leave Medical Device Makers Insecure
      • Contract Design for Medtech
      • Diabetes Medical Device Technology Update
      • Medtech Full-Service Outsourcing Q&A 2022

      Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
      You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

      • About Us
      • Privacy Policy
      • Terms And Conditions
      • Contact Us

      follow us

      Subscribe
      Nutraceuticals World

      Latest Breaking News From Nutraceuticals World

      Thorne Relaunches Gut Health Test with Microbiome Wipe
      Alkemist Labs Announces Alkemist Assured Seal and Next Generation Transparency Reports
      GC Rieber Foundations Expand Philanthropic Efforts
      Coatings World

      Latest Breaking News From Coatings World

      PPG Sets Goals to Reduce Greenhouse Gas Emissions, Unveils 2021 ESG Report
      Birla Carbon to Present Sustainable Carbon-based Solutions at PaintIndia 2022
      BTC Europe, NXTLEVVEL Biochem to Distribute Biobased & Biodegradable Solvents in Europe
      Medical Product Outsourcing

      Latest Breaking News From Medical Product Outsourcing

      Anumana's ECG Pulmonary Hypertension AI Algorithm Gains Breakthrough Status
      inHEART's 3D Cardiac Modeling Tool Earns FDA Nod
      FDA OKs RapidAI's Pulmonary Embolism Triage, Notification Tool
      Contract Pharma

      Latest Breaking News From Contract Pharma

      Corealis CDMO Completes Deal with ArchiMed
      Piramal Pharma Solutions Upgrades Oral Solid Dose Capabilities
      Steriline Robotic Applications to Improve Quality in Drug Primary Packaging
      Beauty Packaging

      Latest Breaking News From Beauty Packaging

      L'Oreal CEO Nicolas Hieronimus On Sustainability Initiatives
      Glossier Announces New CEO
      Men’s Skincare Market to Hit $13 Billion by End of 2022
      Happi

      Latest Breaking News From Happi

      IFSCC Extends 2022 Early Bird Registration
      Incorrect INCI Prompts Recall of Higher Education Vegan Lip Balm
      Hipdot Launches Girl Scout Cookie-Themed Makeup Collection
      Ink World

      Latest Breaking News From Ink World

      HP Indigo Reaches 2,000th Active Install
      Siegwerk Introduces New NC-Based Flexible Packaging Ink
      Sun Chemical Expands SunColorBox with SunConnect
      Label & Narrow Web

      Latest Breaking News From Label & Narrow Web

      AWA to host 22nd Global Release Liner Industry Conference & Exhibition
      Domino assists Grace Label with supply chain disruptions
      Rotocon wins AI Business Excellence Award
      Nonwovens Industry

      Latest Breaking News From Nonwovens Industry

      Thorne Relaunches Gut Health Test with Microbiome Wipe
      Thinx Names Meghan Davis as CEO
      Kimberly-Clark Reportedly Examining Sale of Latin American Tissue
      Orthopedic Design & Technology

      Latest Breaking News From Orthopedic Design & Technology

      Extremity Medical Rolls Out OMNI Stable Ankle Fracture System
      James W. Stone Named AANA President
      Tom Hedman Named Senior Principal Scientist at Spinal Simplicity
      Printed Electronics Now

      Latest Breaking News From Printed Electronics Now

      Canatu Receives IATF 16949:2016 Certification
      Applied Materials Announces 2Q 2022 Results
      ams OSRAM Supervisory Board to Elect Dr. Margarete Haase as Chairwoman

      Copyright © 2022 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

      AD BLOCKER DETECTED

      Our website is made possible by displaying online advertisements to our visitors.
      Please consider supporting us by disabling your ad blocker.


      FREE SUBSCRIPTION Already a subscriber? Login